The U.S Food and Drug Administration's (FDA) vaccine advisory panel is meeting Friday to consider drug partner Pfizer-BioNTech's application to offer their COVID-19 vaccine as a third-dose booster for patients 16 and older.
More
The U.S Food and Drug Administration's (FDA) vaccine advisory panel is meeting Friday to consider drug partner Pfizer-BioNTech's application to offer their COVID-19 vaccine as a third-dose booster for patients 16 and older.
More